Home Duke University Press
 QUICK SEARCH:   [advanced]


     
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


First published on August 17, 2007
This version was published on October 1, 2007
Neuro Oncol 2007 9(4):447-453; DOI:10.1215/15228517-2007-027
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
9/4/447    most recent
15228517-2007-027v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Balasubramaniam, A.
Right arrow Articles by Guha, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Duke University Press

Case Studies

Glioblastoma multiforme after stereotactic radiotherapy for acoustic neuroma: Case report and review of the literature

Anandh Balasubramaniam, Patrick Shannon, Mojgan Hodaie, Normand Laperriere, Howard Michaels and Abhijit Guha

Arthur and Sonia Labatt Brain Tumor Center, Hospital for Sick Children Research Institute, Toronto, ON M5T-2S8, Canada (A.B., A.G.); Department of Neurosurgery, National Institute of Mental Health and Neurosciences, Bangalore, 560029 India (A.B.); Department of Pathology (P.S.) and Division of Neurosurgery (M.H., A.G.), Western Hospital, University Health Network, Toronto, ON, M5T-2S8 Canada; and Departments of Radiation Oncology (N.L.) and Clinical Physics (H.M.), Princess Margaret Hospital, University Health Network, Toronto, ON, M5G-2M9 Canada

Address correspondence to Abhijit Guha, Arthur and Sonia Labatt Brain Tumor Center, Hospital for Sick Children, University of Toronto, 399 Bathurst St., 4W-446, Toronto, ON M5T-2S8, Canada (Abhijit.Guha{at}uhn.on.ca).

Indications for the use of radiotherapy in the management of a variety of benign intracranial neoplastic and nonneoplastic pathologies are increasing. Although the short-term risks are minimal, the long-term risks of radiation-induced de novo secondary neoplasms or malignant progression of the primary benign tumor need to be considered. There are currently 19 reported cases of tumors linked with stereotactic radiotherapy/radiosurgery, to which we add our second institutional experience of a patient who succumbed to a glioblastoma multiforme (GBM) after stereotactic radiotherapy for an acoustic neuroma (AN). Review of these 20 cases revealed 10 de novo secondary tumors, of which eight were malignant, with six being malignant gliomas. The majority of the cases (14 of 20) involved AN, with most being in patients with neurofibromatosis-2 (NF2; 8 of 14), reflecting the large numbers and long-term use of radiotherapy for AN. Accelerated growth of the primary benign AN, some 2 to 6 years after focused radiotherapy, was found in six of eight NF2 patients, with pathological verification of a malignant nerve sheath tumor documented in most. The exact carcinogenic risk after radiotherapy is unknown but likely extremely low. However, the risk is not zero and requires discussion with the patient, with specific consideration in young patients and those with a cancer predisposition.

Key Words: acoustic neuroma • neurofibromatosis-2 • radiation-induced GBM • radiosurgery


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
J. Mukherjee, D. Kamnasaran, A. Balasubramaniam, I. Radovanovic, G. Zadeh, T.-R. Kiehl, and A. Guha
Human Schwannomas Express Activated Platelet-Derived Growth Factor Receptors and c-kit and Are Growth Inhibited by Gleevec (Imatinib Mesylate)
Cancer Res., June 15, 2009; 69(12): 5099 - 5107.
[Abstract] [Full Text] [PDF]




  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Copyright 2007 by Society for Neuro-Oncology